1. Home
  2. CRMT vs QNCX Comparison

CRMT vs QNCX Comparison

Compare CRMT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

N/A

Current Price

$2.35

Market Cap

19.7M

ML Signal

N/A

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

N/A

Current Price

$31.88

Market Cap

17.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRMT
QNCX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
17.5M
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
CRMT
QNCX
Price
$2.35
$31.88
Analyst Decision
Buy
Hold
Analyst Count
2
2
Target Price
$29.50
N/A
AVG Volume (30 Days)
176.9K
19.6K
Earning Date
06-11-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,281,502,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.08
52 Week High
$37.45
$35.41

Technical Indicators

Market Signals
Indicator
CRMT
QNCX
Relative Strength Index (RSI) 39.30 58.65
Support Level $2.13 $29.95
Resistance Level $3.67 $35.38
Average True Range (ATR) 0.22 2.11
MACD 0.03 -0.80
Stochastic Oscillator 24.19 35.81

Price Performance

Historical Comparison
CRMT
QNCX

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: